Illumina Inc (ILMN)
Illumina is engaged in sequencing- and array-based solutions for genetic and genomic analysis. Co.'s products and services enable the adoption of genomic solutions in research and clinical settings. Co.'s principal products, services, and technologies are: sequencing, which includes Deoxyribonucleic acid (DNA) sequencing, a process of determining the order of nucleotide bases (A, C, G, or T) in a DNA sample; arrays, which are used for a range of DNA and RNA analysis applications; consumables, which Co. has developed various library preparation and sequencing kits; and services, which provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.
ILMN SEC Filing Email Alerts Service
| Company Name: |
Illumina Inc |
| Stock buyback: |
ILMN buyback |
| Website: |
www.illumina.com |
| Sector: |
Biotechnology |
| Number of ETFs Holding ILMN: |
102 |
| Total Market Value Held by ETFs: |
$3.48B |
| Total Market Capitalization: |
$19.43B |
| % of Market Cap. Held by ETFs: |
17.90% |
|
|
April 26, 2024 • 8:58 PM Eastern
Buy (2.78 out of 4)
16th percentile
|
|
Free ILMN Email Alerts:
